| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 301.769 | 940.177 | 1.327.812 | 1.172.647 | 2.258.637 | 3.290.344 | 3.201.845 | 3.485.144 |
| Total Income - EUR | - | - | 301.848 | 940.372 | 1.328.430 | 1.174.341 | 2.260.970 | 3.293.483 | 3.637.821 | 3.658.347 |
| Total Expenses - EUR | - | - | 27.036 | 107.918 | 299.932 | 604.785 | 1.141.016 | 1.419.012 | 2.171.845 | 2.185.223 |
| Gross Profit/Loss - EUR | - | - | 274.812 | 832.454 | 1.028.498 | 569.557 | 1.119.954 | 1.874.471 | 1.465.976 | 1.473.124 |
| Net Profit/Loss - EUR | - | - | 267.632 | 823.052 | 956.746 | 478.613 | 966.110 | 1.824.795 | 1.259.267 | 1.245.767 |
| Employees | - | - | 1 | 8 | 13 | 11 | 14 | 14 | 14 | 15 |
Check the financial reports for the company - Trialuri Clinice Oncologie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.424.129 | 2.377.712 | 8.573.738 | 12.399.262 | 12.618.971 | 14.298.091 | 14.783.652 | 14.944.157 |
| Current Assets | - | - | 167.431 | 339.482 | 2.617.163 | 525.961 | 336.714 | 735.024 | 317.036 | 649.607 |
| Inventories | - | - | 0 | 0 | 5.160 | 31.841 | 0 | 0 | 0 | 44.837 |
| Receivables | - | - | 2.751 | 234.408 | 2.445.165 | 332.787 | 150.079 | 215.953 | 151.716 | 249.651 |
| Cash | - | - | 164.679 | 105.074 | 166.838 | 161.333 | 186.635 | 519.071 | 165.320 | 355.119 |
| Shareholders Funds | - | - | 267.676 | 823.104 | 1.763.909 | 2.209.083 | 3.126.204 | 2.060.998 | 3.314.015 | 4.541.261 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.323.884 | 1.894.090 | 9.426.992 | 10.718.140 | 9.832.619 | 12.981.024 | 11.796.629 | 11.061.725 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Trialuri Clinice Oncologie Srl